Plain-English translation of NCT06916260 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a non-invasive light therapy treatment that delivers low-level light waves to the front part of your head. Researchers want to see if this simple 12-minute treatment, done three times a week for six weeks, can help improve both the thinking and movement problems that come with Parkinson's disease. The study will compare people who receive the real light therapy with people who receive a placebo (fake) light therapy to understand if it actually works.
Parkinson's disease affects how people move and think, and current treatments don't work equally well for everyone. Researchers are exploring whether this new light-based approach might offer another option to help manage these symptoms.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll come to the lab three times a week for 6 weeks to receive the light therapy treatment—each session lasts only 12 minutes. Before your first treatment and after your last one, you'll complete some thinking and movement tests so researchers can see if anything has changed. The study also includes a 3-month follow-up visit to check if any effects last over time. Half the participants will receive the real light therapy, and half will receive a placebo version that looks similar but delivers no actual light.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States